Advertisement

Topics

Tosk, Inc. Company Profile

01:12 EDT 15th August 2018 | BioPortfolio


News Articles [2 Associated News Articles listed on BioPortfolio]

National Cancer Institute Awards Tosk $2 Million Cancer Drug Development Grant

Tosk, Inc. announced today that it has received a two-year, $2 million Phase II SIBR grant from the National Cancer Institute (NCI) to support its kRAS oncogene drug research and ...

Deals this week: AzurRx BioPharma, Innovent Biologics, Tosk

AzurRx BioPharma plans to raise $50m through a public offering of securities. The company intends to issue the securities periodically in...Read More... The post Deals this week: AzurRx BioPharma, In...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Tosk Inc.

Tosk was founded in 1998 to discover new drugs for genetic diseases and cancer. The original technology, in part licensed from Stanford University,StealthGene and Targeted Gene Delivery technologies. ...

Tosk, Inc.

Tosk Incorporated

Neurodegenerative diseases and cancer. The Company’s AON QTS technology not only targets the neurodegeneration process, which will allow discovered drugs to be applicable to a variety of AON disease...

More Information about "Tosk, Inc." on BioPortfolio

We have published hundreds of Tosk, Inc. news stories on BioPortfolio along with dozens of Tosk, Inc. Clinical Trials and PubMed Articles about Tosk, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tosk, Inc. Companies in our database. You can also find out about relevant Tosk, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record